U.S. Hospitality Stock News

3M (MMM) has just opened its Q1 2026 reporting season conversation with a recent run of results that saw quarterly revenue range from US$5.95 billion to US$6.52 billion through 2025, alongside basic EPS moving between US$1.08 and US$2.05 as net income fluctuated from US$577 million to US$1.12 billion. Over the same stretch, revenue has moved from US$6.01 billion in Q4 2024 to US$6.13 billion in Q4 2025, while basic EPS shifted from US$1.34 to US$1.08. This sets a backdrop where investors are...

In April 2026, GE HealthCare and RadNet’s DeepHealth expanded their global collaboration to integrate DeepHealth’s AI-powered Breast Suite and new second-reader workflows into GE HealthCare’s Senographe Pristina and Pristina Via mammography platforms, while also showcasing advanced breast imaging technologies at the SBI 2026 Breast Cancer Imaging Symposium. This move deepens GE HealthCare’s role in AI-enabled breast cancer screening by pairing cloud-based, modular applications with its...

A ceasefire agreement in the Middle East is expected to ease geopolitical tensions and reduce near-term uncertainty. Market participants anticipate a release of delayed M&A and capital markets activity as corporate boards revisit postponed transactions. Jefferies Financial Group (NYSE:JEF) is exposed to this trend through its advisory, brokerage, and investment banking businesses. For Jefferies Financial Group, the core story centers on client activity rather than balance sheet moves or...

BOK Financial (BOKF) opened 2026 with Q1 revenue of US$553.8 million and basic EPS of US$2.59, while trailing twelve month revenue sat at US$2.23 billion and EPS at US$9.88. This provides a clear snapshot of the bank's recent earnings power. Over the past year, revenue has moved from US$2.03 billion to US$2.23 billion and trailing twelve month EPS has gone from US$8.14 to US$9.88, giving investors a cleaner read on how the income statement is scaling. With net income on a trailing basis at...

RTX (RTX) opened the new year with Q1 2026 results coming on the heels of Q4 2025 revenue of US$24.2b and basic EPS of US$1.21, supported by Q4 net income of US$1.6b. Over the last six reported quarters, revenue moved from US$21.6b in Q4 2024 to US$24.2b in Q4 2025, while quarterly basic EPS ranged from US$1.10 to US$1.43. This sets up trailing twelve month EPS of US$5.02 and net income of US$6.7b as the reference point for today’s update, so the focus now is on how Q1 margins held up against...

Halliburton (HAL) has just opened its books on the latest period, with trailing 12 month revenue most recently sitting at about US$22.2b and basic EPS shifting from US$2.84 a year ago to US$1.50 on the most recent trailing view, setting a very different earnings backdrop for investors to interpret. Over the last reported quarters, quarterly revenue has moved between US$5,417m and US$5,697m while basic EPS has ranged from US$0.02 to around US$0.70, giving a wide spread of earnings outcomes...

On March 30, 2026, Butterfly Network announced it had secured FDA approval for its AI-powered handheld ultrasound tool that estimates gestational age to support clinicians in emergency and rural settings. This clearance highlights Butterfly’s effort to pair portable imaging hardware with embedded AI, aiming to broaden access to maternal care in underserved communities. We’ll now examine how FDA clearance of Butterfly’s gestational-age AI tool may influence its investment narrative and...

If you are wondering whether Micron Technology's current share price lines up with its underlying value, this breakdown will help you connect the recent moves in the stock with what you are actually paying for. The stock last closed at US$449.38, with returns of 6.3% over the past 30 days, a 42.5% gain year to date, and a very large return over the past year that is above 500%. Recent headlines have focused on Micron as a key name in the semiconductor space, with investors closely watching...

Mercantile Bank (MBWM) just posted another quarter of steady profitability, with Q4 2025 revenue at US$61.8 million and net income of US$22.8 million, which translates into basic EPS of US$1.40 ahead of its Q1 2026 reporting period. Over recent quarters the bank has seen revenue move from US$56.3 million in Q4 2024 to US$61.8 million in Q4 2025, while basic EPS increased from US$1.22 to US$1.40, giving investors a clear picture of consistent earnings power heading into the new year. With...

AbCellera Biologics recently announced that it will share interim Phase 1 data for ABCL635, its potential first-in-class non-hormonal antibody targeting the neurokinin 3 receptor for menopausal vasomotor symptoms, during its first-quarter 2026 earnings call on May 11, 2026. This update marks the first clinical readout from AbCellera’s GPCR and ion channel platform, highlighting how its transition into a clinical-stage pipeline is beginning to be tested in humans. We’ll now examine how the...

In April 2026, Zymeworks Inc. presented six sets of new preclinical data at the AACR Annual Meeting, highlighting progress across its antibody-drug conjugate and novel payload programs targeting RAS-mutant and other hard-to-treat cancers. The breadth of first-in-class ADC constructs and new payload classes, including pan-RAS and mRNA translation inhibitors, underscores Zymeworks’ ambition to build a differentiated oncology technology stack rather than rely on a single lead asset. We’ll now...

Parker-Hannifin recently reported its third-quarter results, with Wall Street having expected diluted EPS of $7.81, an increase of 12.5% from $6.94 a year earlier. Investor attention is heightened because the company has outpaced consensus EPS forecasts in each of the previous four quarters, raising interest in whether that pattern can continue. Next, we will examine how expectations for double-digit EPS growth this quarter affect Parker-Hannifin’s broader investment narrative and long-term...

Recent performance snapshot Acadia Healthcare Company (ACHC) has drawn attention after a recent share price move, with the stock closing at $27.84 and posting gains over the past week, month and past 3 months. See our latest analysis for Acadia Healthcare Company. The recent 1 day share price return of 3.11% sits within a strong run, with a 30 day share price return of 22.48% and a 90 day share price return of 95.51%. However, the 3 year total shareholder return of negative 62.31% shows that...

What Toll Brothers’ recent returns tell you Toll Brothers (TOL) has drawn attention after an 11.6% move over the past month, adding to a 61.1% total return over the past year and 151.3% over five years. With a market value of about US$13.9b, Toll Brothers generates US$11.3b in revenue and US$1.4b in net income. This positions it as a large US luxury homebuilder with nationwide exposure across several regional segments. See our latest analysis for Toll Brothers. That recent 11.6% 1 month share...

In April 2026, Prologis reported first-quarter 2026 results showing sales of US$2,125.08 million, revenue of US$2,297.72 million, and net income of US$981.98 million, while also raising its full-year 2026 net earnings guidance range for common stockholders to US$3.80–US$4.05 per share. Alongside these results, Prologis deepened its global logistics footprint through the planned Prologis Logistics Investment Venture Europe with La Caisse and highlighted growing data center ambitions with new...

Axsome Therapeutics recently attracted attention after Oppenheimer highlighted an “attractive setup” around the now-past US FDA priority review decision on expanding Auvelity’s label to include Alzheimer’s disease agitation. The broker emphasized Auvelity’s differentiated safety profile and potential for longer-term use, arguing these features could support advantageous formulary positioning versus competing treatments. Next, we’ll examine how expectations around the Alzheimer’s agitation...

Fidelis Insurance Holdings Ltd. recently completed the early redemption of its 6.625% Fixed-Rate Junior Notes due April 1, 2041, leading to their de-listing from the Bermuda Stock Exchange effective April 8, 2026, under Regulation 6.17 (3). This early redemption highlights an active reshaping of Fidelis’s capital structure, which may influence how investors assess its balance sheet flexibility and funding mix. We’ll now examine how Fidelis’s early redemption and de-listing of junior notes...

In April 2026, Proto Labs launched ProDesk by Protolabs, an upgraded e-commerce platform that offers real-time AI-powered quoting, design-for-manufacturability analysis, and collaboration tools aimed at accelerating aerospace product development from prototyping through production. This move highlights Proto Labs’ push to embed AI deeper into its digital manufacturing workflow, potentially making it a more integral partner for aerospace and other complex, regulated industries. Next, we’ll...

Alpha and Omega Semiconductor recently celebrated the inauguration of Kaynes Semicon’s OSAT facility in Sanand, Gujarat, where its proprietary IPM5 manufacturing process is now in high-volume production for global power semiconductor customers. By bringing advanced packaging and testing capabilities online in just 14 months, the collaboration deepens Alpha and Omega Semiconductor’s manufacturing presence in India while supporting the India Semiconductor Mission’s goal of building...

Recent commentary on MYR Group highlights concern that its sales pipeline and average backlog growth of 5.4% over the past two years may not support earlier revenue growth expectations. With a forward P/E ratio of 34.2x, MYR Group’s weaker gross margin of 10.8% and waning returns on capital are drawing attention to potential profitability pressure. Next, we’ll examine how concerns about MYR Group’s slower backlog growth may reshape its previously measured, contract-driven investment...

Four Corners Property Trust recently acquired a National Veterinary Associates property in a strong California retail corridor for US$4,400,000 under a long-term, net lease at a 7.1% cap rate, excluding transaction costs. This veterinary asset adds an essential service tenant to FCPT’s portfolio, underscoring its shift toward more resilient, non-restaurant income streams. Next, we’ll examine how adding a long-term, net-leased veterinary property may influence Four Corners Property Trust’s...

Fermi Inc. recently reshaped its leadership and governance, with co-founder Toby Neugebauer stepping down as CEO, Miles Everson resigning as CFO to join the board, the creation of an interim Office of the CEO led by Co-Presidents Jacobo Ortiz Blanes and Anna Bofa, and the appointment of Jeffrey S. Stein as a new director, while also committing to new headquarters in Dallas and expanded offices at Project Matador in Amarillo. Together, these moves mark a shift from founder-led management to a...

Sensient Technologies recently announced it will invest up to US$250,000,000 to expand natural color production, adding 28,800 square feet at its St. Louis plant to meet rising reformulation demand from food manufacturers. Management has described the shift to natural colors as the largest opportunity in the company’s history, signaling a meaningful scale-up of its clean-label ingredients focus. We’ll now examine how Sensient’s US$250,000,000 natural color capacity expansion could reshape...

Wolfe Research has identified Trex Company (TREX) as a preferred name in building products, citing relatively lower inflationary risk at a time when peers are dealing with soft demand and rising input costs. See our latest analysis for Trex Company. Recent momentum has been strong, with a 20.89% 1 month share price return and 21.43% year to date share price return, even as the 1 year total shareholder return shows an 18.92% decline. If Trex’s recent move has you thinking about what else could...